generic voriconazole tablets — Cigna

Preferred products

• generic voriconazole tablets
• generic voriconazole oral suspension

Initial criteria

• Request is for Vfend (voriconazole tablets or oral suspension) or generic voriconazole tablets or oral suspension
• Patient meets the indication criteria listed (either FDA-approved or supported use)
• When clinically appropriate, the patient is directed to try the generic voriconazole (Step 1) prior to brand Vfend (Step 2)

Reauthorization criteria

• Continuation of therapy to complete the approved course

Approval duration

3–12 months (as specified per indication)